Cytosurge AG
Gregor Schuchter is an experienced operations and business professional currently serving as Head of Operations for the Instrument Business at Cytosurge since January 2024. Prior to this role, Schuchter was a Co-Managing Director and board member at Robolem AG from February 2018 to December 2023, and previously co-founded the company. Schuchter also held the position of Supply Chain Manager and Team Leader of Production at Zurich Instruments AG from October 2013 to January 2022. Earlier career experiences include Team Leader Operations Quality Engineer at Tecan, Junior Production Engineer at QIAGEN, and completing an apprenticeship as an Electronics Technician at Swissphone Wireless AG. Schuchter holds a Professional Bachelor in Business Processes and an Electronic Technician certification, with education attained at sfb - esg - soa and TBZ Technische Berufsschule Zürich.
This person is not in any teams
Cytosurge AG
Cytosurge AG, founded in 2009, is a biotechnology company that manufactures and distributes cutting-edge solutions based on its patented FluidFM® technology. At the heart of this technology are the hollow FluidFM Probes – the Micropipette, Nanopipette, and the Nanosyringe – specifically designed to offer a wide range of unique applications for single-cell manipulation in biology research. Cytosurge's current systems compatible with FluidFM probes include the FluidFM ADD-ON for AFM systems and the standalone semi-automated FluidFM OMNIUM system. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, contributing to human well-being through advancements in single-cell technologies. As the partner of choice for precision gene engineering cell line manufacturing, Cytosurge enables next-generation biologic production and cell and gene therapy treatments, empowering people to live longer and healthier lives. Cytosurge implements advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and the manufacturing of high-precision gene-engineered cell lines. With a unique single-cell workflow and dynamic gene expression analytics, Cytosurge manufactures advanced gene-engineered cell lines, empowering next-generation treatments to benefit human well-being.